Indefinite Delivery Contract 36C25625D0086

Award Date 6/13/25
Last Date to Order 9/30/29
Contracting Federal Agency
Veterans Integrated Service Network 16
Ultimate Awardee
Not listed
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Inventory
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) Strategic Acquisition Center-Frederick, a civilian agency, to Fulgent Therapeutics LLC, a subsidiary of Fulgent Genetics, Inc. The $99,032,828.20 multiple-award IDC provides national access to germline genetic testing for oncology, medical genetics, and pharmacogenomic testing for VA patients through September 2029. The IDC includes a $2,300,000 fixed-price task order for "GERMLINE PGX...
The Department of Veterans Affairs Veterans Health Administration has awarded a single-award Indefinite Delivery Contract (IDC) worth $1,140,000 to Broad Clinical Laboratories, LLC of Cambridge, Massachusetts. This IDC has a period of performance through February 6, 2029 and is designed to provide genetic testing services to VA medical facilities within Veterans Integrated Service Network 1, which covers northern New England. Under the initial $270,000 firm fixed price delivery order, Broad...
The Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) to Infinity Biologix LLC, doing business as Sampled Division, for genomic analysis services worth up to $86.5 million over the period of performance ending September 29, 2025. This single-award IDC was issued by the VA Headquarters and does not include any socioeconomic set-asides. Under this IDC, the VA has issued multiple firm-fixed-price delivery orders to Infinity Biologix for genomic sequencing, DNA...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA), Network Contracting Office (NCO) 21, to Diacarta, Inc. for reference laboratory testing services to aid in the diagnosis of VEXAS Syndrome. The contract has a total ceiling value of $200,000 and a period of performance from October 1, 2024 to September 30, 2029. The key services under this contract include specimen pickup, testing for somatic mutations of the UBA1 gene, reporting, and consultation....
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., operating as Cblpath, to provide ThyroSeq laboratory tests to determine the malignancy of thyroid nodules in order to support surgical decisions for veterans. The single-award IDC has a ceiling value of $500,000 and a period of performance through August 6, 2026. Under this IDC, the VA has issued multiple firm-fixed-price delivery orders ranging from $22,000 to $72,000...
This indefinite delivery contract (IDC) was awarded by the Veterans Integrated Service Network 9 (VISN 9), a civilian federal agency, to Genben Lifesciences Corp, a woman-owned small business. The contract has a ceiling value of $56,810 and a period of performance through March 31, 2030. The purpose of this IDC is to provide specialty tests and receive corresponding results for the agency. The contract does not utilize any set-asides and was a single award. Based on the general description...
The Department of Veterans Affairs (VA) awarded an Indefinite Delivery Contract (IDC) worth up to $147,080 to Natera Inc. to provide next generation sequencing and peripheral blood circulating tumor DNA (ctDNA) testing services in support of a VA-funded research study. The contract has a single award, no set-aside, and a period of performance from March 2025 to March 2028. The initial delivery order under this IDC is for $496,460 to fund research and development activities related to minimal...
The U.S. Department of Veterans Affairs (VA) awarded a $130.7 million Indefinite Delivery Contract (IDC) to Foundation Medicine, Inc., a leading provider of genomic profiling and molecular analysis services, for specialized tumor molecular profiling services. This single-award IDC, with a completion date of September 12, 2029, aims to provide the VA's National Precision Oncology Program with comprehensive genomic profiling for both solid and hematological malignancies. The contracted services...
The Department of Veterans Affairs (VA) Strategic Acquisition Center-Frederick awarded an Indefinite Delivery, Indefinite Quantity (IDIQ) contract to Baylor Miraca Genetics Laboratories LLC, doing business as Baylor Genetics, for the provision of germline pharmacogenomics (PGx) molecular testing services. The $982,402.00 firm fixed-price task order has an ultimate completion date of September 29, 2025 and supports the VA's medical research and development efforts. This IDIQ contract is part of...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a single-award indefinite delivery contract to Ambry Genetics Corporation to provide specialized genetic reference laboratory testing services in support of VA programs. The contract has a potential value of $2,085,930 and a period of performance through March 2026. Under the contract, Ambry Genetics has been issued four firm-fixed price delivery orders to date for laboratory...

This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA), specifically the Michael E. DeBakey VA Medical Center (MEDVAMC) Pathology & Laboratory Medicine Service, to Ailife Diagnostics, Inc., a woman-owned small business. The contract, valued at up to $1,121,500.00, is for the provision of comprehensive physician-authorized genetic testing services to support the diagnosis and medical management of veteran patients. The contract includes over 200 specific genetic tests across multiple categories such as cancer, cardiovascular, neurological, metabolic, immunological, and rare genetic disorders. This is a single-award IDC with a base year from June 13, 2025, to September 30, 2025, and four 12-month option years potentially extending the contract through September 30, 2029. The place of performance is Houston, TX 77030. This procurement was designated as a Total Small Business Set-Aside under NAICS code 621511, with a size standard of $41.5 million. The contract aims to address the critical need for these genetic tests to support the diagnosis, medical management, and reproductive planning of veteran patients in alignment with national guidelines.

Generated 6/10/25, 10:44 AM